Loading...
Bilateral Trade Intelligence · $178.0M Total Trade · 420 Exporters · 657 Buyers · DGFT Verified · Updated March 2026
India exported $178.0M worth of pharmaceutical formulations to Malaysia across 21,835 verified shipments, sourced from 420 Indian exporters supplying 657 Malaysia buyers. The top exporters are BABA AGENCIES ($33.9M) and SHIFAA PHARMA ($8.7M). The leading products are Ayurvedic ($3.1M). Average shipment value: $8.2K.
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Nootropil IV Vial 60ml | $3.2M | 1.8% |
| 2 | Typbar Multidose (typhoid 2.5 Ml) | $3.2M | 1.8% |
| 3 | Medicaments of Ayurvedic System, Av Uri-k Capsules ,batch No. 2322 | $3.1M | 1.7% |
| 4 | Medicines. Ethionamide 250 MG Tablets | $2.7M | 1.5% |
| 5 | Quadri Meningo (meningoccoal) | $2.7M | 1.5% |
| 6 | Stop Cof (in Pet Bottle with Carton Meas | $2.5M | 1.4% |
| 7 | Tufacane 10mg 10s (tufacane 10mg 10s) | $2.0M | 1.2% |
| 8 | Insugen R Refil-5x3 ML | $1.9M | 1.1% |
| 9 | Mifegest Kit Tablets | $1.8M | 1.0% |
| 10 | Cofcare Syrup (jerrican)5 Ltr | $1.7M | 1.0% |
| 11 | Mifegest Kit Tablets 1"s | $1.7M | 0.9% |
| 12 | Cytolog Tablets 4s | $1.6M | 0.9% |
| 13 | Insugen-30/70 Refil# 3ml 5x3 Ml-multi | $1.4M | 0.8% |
| 14 | Cofcare Syrup 100 ML | $1.4M | 0.8% |
| 15 | Asthalin 100mcg Inhaler (1 X 200 Md) | $1.2M | 0.7% |
India exports 20+ pharmaceutical formulations to Malaysia with a combined trade value of $178.0M. Key products include Ayurvedic ($3.1M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 21,835 verified Indian Customs (DGFT) shipment records.
These are the top pharmaceutical products exported from India to Malaysia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Malaysia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Ayurvedic ($3.1M) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
India exported pharmaceuticals worth $178.0M to Malaysia across 21,835 verified shipments.
1. BABA AGENCIES — $33.9M. 2. SHIFAA PHARMA — $8.7M. 3. TORRENT PHARMACEUTICALS LTD — $7.7M. Total: 420 suppliers.
1. NILA JAMAL ENTERPRISE — $26.3M. 2. DKSH MALAYSIA SDN BHD — $9.5M. 3. UNIMED SDN BHD — $9.1M. 657 buyers total.
1. Nootropil IV Vial 60ml ($3.2M, 1.8%); 2. Typbar Multidose (typhoid 2.5 Ml) ($3.2M, 1.8%); 3. Medicaments of Ayurvedic System, Av Uri-k Capsules ,batch No. 2322 ($3.1M, 1.7%); 4. Medicines. Ethionamide 250 MG Tablets ($2.7M, 1.5%); 5. Quadri Meningo (meningoccoal) ($2.7M, 1.5%)
Export: CHENNAI AIR, NHAVA SHEVA SEA (INNSA1), HYDERABAD AIR, SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4). Import: KUALA LUMPUR - INT'L, Port Kelang, PORT KELANG, KUALA LUMPUR INT L, Westport/Port Klang.
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $178.0M corridor reflects quality compliance and pricing advantages.
420 Indian pharmaceutical companies export finished formulations to Malaysia. Leading exporters include Baba Agencies, Shifaa Pharma, Torrent Pharmaceuticals Ltd, Biocon Biologics Limited. The top exporter accounts for 19.1% of total India–Malaysia pharma exports. Source: Indian Customs (DGFT).
657 companies in Malaysia import pharmaceutical formulations from India. Top buyers include Nila Jamal Enterprise, Dksh Malaysia Sdn Bhd, Unimed Sdn Bhd, Efs Logistics Sdn Bhd,. The largest buyer accounts for 14.8% of India–Malaysia pharma imports. Source: Indian Customs (DGFT).
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
$8.2K per consignment across 21,835 shipments.
420 Indian companies. Largest: BABA AGENCIES with $33.9M.
TransData Nexus covers 420 active exporters with shipment history and trade values at transdatanexus.com.
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 21,835 shipments.
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
420 Exporters
657 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists